NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

3M Beats Q4 Earnings But 2026 Guidance Disappoints Investors

3M surpasses Q4 2025 earnings estimates with $1.83 adjusted EPS as cost cuts and innovation drive growth, though 2026 guidance disappoints investors.

3M Beats Q4 Earnings But 2026 Guidance Disappoints Investors
Credit: Andrew Harrer/Bloomberg
Already have an account? Sign in.
01/20/2026 · 7:15 AM
MMM
/ Don’t stop at just one post.

Related↓

3M
10/21/2025 · 12:43 PM

3M Raises 2025 Profit Forecast on Strong Product Innovation and Cost Cuts

3M boosts annual profit outlook for second time in 2025, driven by new product launches, margin expansion, and CEO Bill Brown's cost-cutting strategy. Shares jump 6%.

/ Subscriber only
/ Read more

Feed↓

SpaceX to Join Nasdaq-100 on July 7: $4.3 Billion Passive Buying Wave Incoming
Featured/ 06/27/2026 · 1:18 AM

SpaceX to Join Nasdaq-100 on July 7: $4.3 Billion Passive Buying Wave Incoming

Despite the massive demand boost, analysts remain cautious, citing the company’s $4.9 billion net loss last year and concerns over valuation.

/ Subscriber only
Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised
06/26/2026 · 4:53 PM

Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised

The delay is due to manufacturing issues at a third-party facility, with no safety or clinical data concerns.

/ Subscriber only
Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle
06/26/2026 · 3:43 PM

Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle

Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe